IGM Biosciences, Inc.
IGMSDelisted Aug 14, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001496323
IGM Biosciences, Inc. was delisted on Aug 14, 2025; its insiders filed their last Form 4 on Aug 18, 2025; 66 institutions reported holding it in 13F filings for Q2 2025, worth $17.9M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding IGM Biosciences, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 105 | 1 | 107 | +3 |
| Shares | 16.3M | 439.3K | 16.9M | +997.9K (+6.3%) |
| Value | $1.36B | $36.5M | $1.11B | −$211.1M (−16.0%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held IGM Biosciences, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pictet Asset Management SA | 584,347 | $38.4M | 0.04% |
| Ikarian Capital, LLC | 51,500 | $3.39M | 0.78% |
| Citadel Advisors LLC | 44,200 | $2.91M | 0.00% |
| Jane Street Group, LLC | 21,708 | $1.43M | 0.00% |
| Millennium Management LLC | 15,514 | $1.02M | 0.00% |
| Virtu Financial LLC | 7,391 | $486.0K | 0.04% |
| Group One Trading, L.P. | 6,970 | $458.0K | 0.01% |
| Cubist Systematic Strategies, LLC | 5,588 | $367.0K | 0.00% |
| Boothbay Fund Management, LLC | 5,139 | $338.0K | 0.01% |
| Caption Management, LLC | 4,668 | $307.0K | 0.02% |
| Wolverine Trading, LLC | 4,160 | $276.0K | 0.01% |
| Trexquant Investment LP | 3,380 | $222.0K | 0.02% |
| Amundi | 2,070 | $136.0K | 0.00% |
| Quadrant Capital Group LLC | 27 | $2.00K | 0.00% |
| Signaturefd, LLC | 11 | $1.00K | 0.00% |
| Parallel Advisors, LLC | 4 | $0 | 0.00% |
Sold out (13)
Institutions that held IGM Biosciences, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 151,390 | $12.6M |
| Candriam Luxembourg S.C.A. | 122,029 | $10.2M |
| Cerity Partners LLC | 7,000 | $582.0K |
| Glenmede Trust Co NA | 4,355 | $362.0K |
| Blueshift Asset Management, LLC | 3,825 | $318.0K |
| AlphaCrest Capital Management LLC | 3,000 | $250.0K |
| Handelsbanken Fonder AB | 2,900 | $241.0K |
| HRT Financial LP | 2,762 | $229.0K |
| Old Well Partners, LLC | 2,619 | $218.0K |
| SEI Investments Co | 2,505 | $208.0K |
| Nisa Investment Advisors, LLC | 600 | $50.0K |
| Bellwether Advisors, LLC | 66 | $5.00K |
| The PNC Financial Services Group, Inc. | 12 | $1.00K |
Not filed for Q3 2021 yet (1)
Institutions that held IGM Biosciences, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 439,297 | $36.5M |